Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment and work by blocking protein interactions that normally prevent the immune system from…

Breast Cancer (Triple Negative Breast Cancer (TNBC))Renal Cell Carcinoma (Kidney Cancer)Melanoma (Skin Cancer)+5 more

~Estimated

~$10 – $7,500

Jessica Mezzanotte SharpeNCT07555210

Phase 2

A Multicenter, Open-Label, Randomized, Controlled Study to Assess the Antitumor Activity of LNS8801 With and Without Pembrolizumab in Patients With Treatment-Refractory, Unresectable Melanoma

The goal of this clinical trial is to understand if a new drug called LNS8801 can safely treat patients with melanoma. The primary question to be answered is w…

Melanoma (Skin Cancer)Melanoma Stage IIIB-IVCutaneous Melanoma+1 more

~Estimated

~$10 – $8,750

Linnaeus Therapeutics, Inc.NCT06624644

← PreviousPage 2 of 2Next →